Aperio Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.75M | Buy |
13,668
+2,064
| +18% | +$264K | 0.01% | 1306 |
|
|
2020
Q3 | $1.31M | Sell |
11,604
-459
| -4% | -$51.7K | ﹤0.01% | 1314 |
|
|
2020
Q2 | $1.15M | Buy |
12,063
+2,927
| +32% | +$279K | ﹤0.01% | 1350 |
|
|
2020
Q1 | $821K | Buy |
9,136
+2,664
| +41% | +$239K | ﹤0.01% | 1388 |
|
|
2019
Q4 | $343K | Sell |
6,472
-59
| -0.9% | -$3.13K | ﹤0.01% | 2001 |
|
|
2019
Q3 | $258K | Buy |
6,531
+1,906
| +41% | +$75.3K | ﹤0.01% | 2082 |
|
|
2019
Q2 | $190K | Buy |
+4,625
| New | +$190K | ﹤0.01% | 2193 |
|